Éric Dion

Title: Éric Dion: Innovator in Antiphage Technology

Introduction

Éric Dion is a notable inventor based in Loretteville, Canada. He has made significant contributions to the field of biotechnology, particularly in the area of phage resistance. His work has implications for both research and practical applications in microbial resistance.

Latest Patents

Éric Dion holds a patent for a fragment of L. lactis plasmid conferring antiphage activity and uses thereof. This invention relates to a 2227-bp DNA fragment that confers antiphage activity. The two proteins encoded by this DNA sequence are responsible for the phage resistance phenotype. When introduced into a phage-sensitive strain, this DNA fragment aborts the infection of phages of the 936 and P335 species. This innovative approach has the potential to enhance the resilience of bacterial strains against phage attacks.

Career Highlights

Éric Dion is affiliated with Université Laval, where he conducts his research and development activities. His work at the university has allowed him to explore various aspects of microbiology and biotechnology. He has focused on developing solutions that address challenges in microbial resistance, contributing to advancements in the field.

Collaborations

Éric collaborates with Julie Bouchard, who is also involved in research at Université Laval. Their partnership has fostered a productive environment for innovation and discovery in their respective fields.

Conclusion

Éric Dion's contributions to antiphage technology exemplify the importance of innovation in biotechnology. His patent and ongoing research efforts highlight the potential for developing new solutions to combat phage-related challenges in microbial applications.